Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-07-06 21:40:18 ET · period of report 2026-07-02 · accession 0001674236-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,313 | 180.9K | +2% | +$164.0K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $86.00 | -3,313 | 177.5K | -2% | -$284.9K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | -3,313 | 3,313 | -50% | -$164.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-02 | M | A | 3,313 | $49.51 | 180,856 | D | — | — | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 2 | Common | Common Stock | 2026-07-02 | S | D | 3,313 | $86.00 | 177,543 | D | — | — | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2026-07-02 | M | D | 3,313 | $49.51 | 3,313 | D | $49.51 · — to 2027-03-30 | 3,313 Common Stock | (F1) The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. (F2) 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. |